Advertisement

Atrion Corporation ATRI

Set alert

Price alert · ATRI

All alert types
459.92 0.00 0.00%

At close · Aug 20

459.75 Day range 460.26

52-week range unavailable

Open
459.75
Prev close
459.92
Mkt cap
809.44M
Vol
29.52K
Avg vol
0
EPS
0.00
P/E
0.00
Div yield
1.91%
More statistics
Low
459.75
High
460.26
Forward P/E
0.00
Beta
0.69
Short ratio
2.04
Inst. own
71.86%
Dividend
8.80
Ex-div date
Jun 13, 2024
Earnings
Aug 8, 2024
50-d avg
457.07
200-d avg
410.03
1y target
0.00

2Y chart

Chart tools
Interval

Chart is warming up

The two-year price history for ATRI has not been loaded yet. Try again in a moment.

Key statistics

Market cap
809.44M
Enterprise value
791.85M
Trailing P/E
64.50
Forward P/E
0.00
PEG ratio
0.00
Price / sales
4.46
Price / book
3.39
EPS (TTM)
7.13
Beta
0.69
Dividend yield
1.91%
Payout ratio
123.60%
Profit margin
6.92%
Revenue (TTM)
181.60M
Revenue growth
11.30%
Free cash flow
26.30M
Total cash
17.59M
Total debt
0
Return on equity
5.23%
Shares outstanding
1.76M
Short % of float
3.79%
50-day average
457.07
200-day average
410.03

Analyst view

Consensus: none

Price target (mean) 0.00
Ratings (0m) 1 0 buy · 0 hold · 1 sell
  • Strong buy0
  • Buy0
  • Hold0
  • Sell1
  • Strong sell0

Next earnings

Aug 8, 2024

Expected Aug 8, 2024. Consensus EPS estimate 0.00.

Earnings history

Financials — quick view

All financials
ATRI Revenue — quarterly 48.77M
2020-Q3 20202020-Q4 20202021-Q1 20212021-Q2 20212021-Q3 20212021-Q4 20212022-Q1 20222022-Q2 20222022-Q3 20222022-Q4 20222023-Q1 20232023-Q2 20232023-Q3 20232023-Q4 20232024-Q1 20242024-Q2 2024
ATRI Net income — quarterly 402.00K
2020-Q3 20202020-Q4 20202021-Q1 20212021-Q2 20212021-Q3 20212021-Q4 20212022-Q1 20222022-Q2 20222022-Q3 20222022-Q4 20222023-Q1 20232023-Q2 20232023-Q3 20232023-Q4 20232024-Q1 20242024-Q2 2024
ATRI EPS — quarterly 0.23
2020-Q3 20202020-Q4 20202021-Q1 20212021-Q2 20212021-Q3 20212021-Q4 20212022-Q1 20222022-Q2 20222022-Q3 20222022-Q4 20222023-Q1 20232023-Q2 20232023-Q3 20232023-Q4 20232024-Q1 20242024-Q2 2024

Earnings

ATRI recent earnings
Report dateQuarter endingEPS estimateEPS reportedSurpriseSurprise %
Aug 8, 2024Jun 1, 20240.00———
May 10, 2024Mar 1, 20240.00———
Feb 29, 2024Dec 1, 20230.00———
Nov 7, 2023Sep 1, 20230.00———
Aug 8, 2023Jun 1, 20230.00———
May 8, 2023Mar 1, 20230.00———

Upgrades / downgrades

ATRI analyst upgrades and downgrades
DateFirmActionFromTo
Apr 24, 2016BWS Financialinit—Sell

About Atrion Corporation

Atrion Corporation, together with its subsidiaries, develops, manufactures, and sells products for fluid delivery, cardiovascular, and ophthalmic applications in the United States, Canada, Europe, and internationally. The company's fluid delivery products include valves that fill, hold, and release controlled amounts of fluids or gasses for use in various intubation, intravenous, catheter, and other applications in the anesthesia and oncology fields, as well as promote infection control in hospital and home healthcare environments. Its cardiovascular products comprise Myocardial Protection System that delivers fluids and medications, and mixes critical drugs, as well as controls temperature, pressure, and other variables; cardiac surgery vacuum relief valves; silicone vessel loops for retracting and occluding vessels; and inflation devices for balloon catheter dilation, stent deployment, and fluid dispensing, as well as products for use in heart bypass surgery. The company's ophthalmic products consist of a line of balloon catheters, which are used for the treatment of nasolacrimal duct obstruction in children and adults. It manufactures products for safe needle and scalpel blade containment; inflation systems and valves used in marine and aviation safety products; components used in inflatable survival products and structures; and one-way and two-way pressure relief valves that protect sensitive electronics and other products during transport in other medical and non-medical applications. The company sells its products to physicians, hospitals, clinics, and other treatment centers; and other equipment manufacturers through direct sales force, independent sales representatives, and distributors. Atrion Corporation was founded in 1944 and is headquartered in Allen, Texas.

Sector
Healthcare
Industry
Medical Instruments & Supplies
Country
United States

News

Your note

Sign in to keep a note on ATRI — it syncs with the Stock Master app.

Insider holders

ATRI insider holders
InsiderRelationLatest transactionDateShares held
ATHEY PRESTON G.DirectorPurchaseNov 30, 20231,368
BANKES JEANNETTEDirectorStock Award(Grant)Sep 19, 2023186
BATTAT DAVID AChief Executive OfficerStock Award(Grant)Aug 20, 20240
BATTAT EMILE ADirectorConversion of Exercise of derivative securityJun 30, 2024150,616
FERGUSON CINDYChief Financial OfficerConversion of Exercise of derivative securityMar 7, 2024118
MORGAN HUGH JACKSON JRDirectorStock Award(Grant)May 22, 202310,348

Institution ownership

ATRI institution ownership
Holder% heldSharesValueReported
Kayne Anderson Rudnick Investment Management LLC11.60%204,079115.45MJun 29, 2023
Neuberger Berman Group, LLC10.56%185,786105.10MJun 29, 2023
T. Rowe Price Investment Management, Inc.6.30%110,80362.68MJun 29, 2023
Blackrock Inc.6.22%109,49461.94MJun 29, 2023
Vanguard Group Inc4.71%82,82746.86MJun 29, 2023
Dimensional Fund Advisors LP2.95%51,99229.41MJun 29, 2023

Fund ownership

ATRI fund ownership
Holder% heldSharesValueReported
Neuberger & Berman Genesis Fund7.02%123,51069.87MJun 29, 2023
Price (T.Rowe) Small-Cap Value Fund3.89%68,51738.76MJun 29, 2023
Virtus Equity Tr-Virtus KAR Small Cap Core Fd2.78%48,88027.65MJun 29, 2023
Vanguard Total Stock Market Index Fund2.26%39,84522.54MJun 29, 2023
iShares Russell 2000 ETF1.72%30,25714.07MAug 30, 2023
Price (T.Rowe) U.S. Small-Cap Value Equity Trust1.68%29,60116.75MJun 29, 2023
Advertisement